UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells

Scientific reports, 2015-08, Vol.5 (1), p.13249-13249, Article 13249

2015

Volltextzugriff (PDF)

Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells

Cancer science, 2021-11, Vol.112 (11), p.4711-4721

2021

Volltextzugriff (PDF)

Tumor suppressor miR‐193a‐3p enhances efficacy of BRAF/MEK inhibitors in BRAF‐mutated colorectal cancer

Cancer science, 2021-09, Vol.112 (9), p.3856-3870

2021

Volltextzugriff (PDF)

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer

Oncotarget, 2018-04, Vol.9 (27), p.18698-18711

2018

Volltextzugriff (PDF)

IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse model

Cancer Immunology, Immunotherapy, 2017-11, Vol.66 (11), p.1485-1496

2017

Volltextzugriff (PDF)

A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer

Cancer science, 2022-03, Vol.113 (3), p.1057-1068

2022

Volltextzugriff (PDF)

Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types

Scientific reports, 2023-03, Vol.13 (1), p.4868-4868, Article 4868

2023

Volltextzugriff (PDF)

Altered gene expression due to aberrant DNA methylation correlates with responsiveness to anti‐EGFR antibody treatment

Cancer science, 2022-09, Vol.113 (9), p.3221-3233

2022

Volltextzugriff (PDF)

BRCA1 transports the DNA damage signal for CDDP‐induced centrosome amplification through the centrosomal Aurora A

Cancer science, 2022-12, Vol.113 (12), p.4230-4243

2022

Volltextzugriff (PDF)

Computational and cellular studies reveal structural destabilization and degradation of MLH1 variants in Lynch syndrome

eLife, 2019-11, Vol.8

2019

Volltextzugriff (PDF)

LPIN1 downregulation enhances anticancer activity of the novel HDAC/PI3K dual inhibitor FK‐A11

Cancer science, 2021-02, Vol.112 (2), p.792-802

2021

Volltextzugriff (PDF)

The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study

PloS one, 2017-06, Vol.12 (6), p.e0179694-e0179694

2017

Volltextzugriff (PDF)

Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201)

BMC cancer, 2024-02, Vol.24 (1), p.262-262, Article 262

2024

Volltextzugriff (PDF)

Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”

International journal of clinical oncology, 2021-03, Vol.26 (3), p.621-621

2021

Volltextzugriff (PDF)

Guidelines for treatment of renal injury during cancer chemotherapy 2016

Clinical and experimental nephrology, 2018-02, Vol.22 (1), p.210-244

2018

Volltextzugriff (PDF)

Antitumor activity and pharmacologic characterization of the depsipeptide analog as a novel histone deacetylase/ phosphatidylinositol 3‐kinase dual inhibitor

Cancer science, 2017-07, Vol.108 (7), p.1469-1475

2017

Volltextzugriff (PDF)

Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei

International journal of clinical oncology, 2020-04, Vol.25 (4), p.774-781

2020

Volltextzugriff (PDF)

TP53 signature diagnostic system using multiplex reverse transcription–polymerase chain reaction system enables prediction of prognosis of breast cancer patients

Breast cancer (Tokyo, Japan), 2021-11, Vol.28 (6), p.1225-1234

2021

Volltextzugriff (PDF)

Current status of medical oncology in Japan and changes over the most recent 7-year period: results of a questionnaire sent to designated cancer care hospitals

Japanese journal of clinical oncology, 2021-11, Vol.51 (11), p.1622-1627

2021

Volltextzugriff (PDF)

Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors

Cancer science, 2015-02, Vol.106 (2), p.208-215

2015

Volltextzugriff (PDF)

Application of targeted nanopore sequencing for the screening and determination of structural variants in patients with Lynch syndrome

Journal of human genetics, 2021-11, Vol.66 (11), p.1053-1060

2021

Volltextzugriff (PDF)

A Concise Approach for Producing Optically Pure Carboxylic Acid Segments for the Synthesis of Bicyclic Depsipeptide Histone Deacetylase Inhibitors

Synthesis (Stuttgart), 2019-03, Vol.51 (6), p.1408-1418

2019

Volltextzugriff (PDF)

Nivolumab-induced Thrombotic Thrombocytopenic Purpura in Patients with Gastric Tube Cancer

Internal Medicine, 2024, pp.2931-23

2024

Volltextzugriff (PDF)

Synthetic lethal interaction of CDK inhibition and autophagy inhibition in human solid cancer cell lines

Oncology reports, 2017-07, Vol.38 (1), p.31-42

2017

Volltextzugriff (PDF)

1 – 25 von 348

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(304)
Mit Volltextzugriff
(311)

Publikationsform

Artikel
(344)
Berichte
(4)

Sprache

Englisch
(309)
Japanisch
(42)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells

Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells

Tumor suppressor miR‐193a‐3p enhances efficacy of BRAF/MEK inhibitors in BRAF‐mutated colorectal cancer

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer

IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse model

A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer

Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types

Altered gene expression due to aberrant DNA methylation correlates with responsiveness to anti‐EGFR antibody treatment

BRCA1 transports the DNA damage signal for CDDP‐induced centrosome amplification through the centrosomal Aurora A

Computational and cellular studies reveal structural destabilization and degradation of MLH1 variants in Lynch syndrome

LPIN1 downregulation enhances anticancer activity of the novel HDAC/PI3K dual inhibitor FK‐A11

Clinical practice guidance for next‐generation sequencing in cancer diagnosis and treatment (Edition 1.0)

The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study

Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201)

Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”

Guidelines for treatment of renal injury during cancer chemotherapy 2016

Antitumor activity and pharmacologic characterization of the depsipeptide analog as a novel histone deacetylase/ phosphatidylinositol 3‐kinase dual inhibitor

Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei

TP53 signature diagnostic system using multiplex reverse transcription–polymerase chain reaction system enables prediction of prognosis of breast cancer patients

Current status of medical oncology in Japan and changes over the most recent 7-year period: results of a questionnaire sent to designated cancer care hospitals

Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors

Application of targeted nanopore sequencing for the screening and determination of structural variants in patients with Lynch syndrome

A Concise Approach for Producing Optically Pure Carboxylic Acid Segments for the Synthesis of Bicyclic Depsipeptide Histone Deacetylase Inhibitors

Nivolumab-induced Thrombotic Thrombocytopenic Purpura in Patients with Gastric Tube Cancer

Synthetic lethal interaction of CDK inhibition and autophagy inhibition in human solid cancer cell lines

Suchergebnisse filtern